Reviewing Titan Medical (NASDAQ:TMDIF) & KORU Medical Systems (NASDAQ:KRMD)

Titan Medical (NASDAQ:TMDIFGet Free Report) and KORU Medical Systems (NASDAQ:KRMDGet Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Volatility and Risk

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500.

Institutional & Insider Ownership

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 0.0% of Titan Medical shares are held by company insiders. Comparatively, 20.6% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Titan Medical and KORU Medical Systems, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical 0 0 0 0 0.00
KORU Medical Systems 0 1 3 1 3.00

KORU Medical Systems has a consensus price target of $4.50, suggesting a potential upside of 49.01%. Given KORU Medical Systems’ stronger consensus rating and higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than Titan Medical.

Profitability

This table compares Titan Medical and KORU Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Titan Medical N/A -82.31% -51.47%
KORU Medical Systems -37.42% -24.60% -16.87%

Earnings and Valuation

This table compares Titan Medical and KORU Medical Systems”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Medical $17.63 million 1.65 $6.95 million $0.05 5.11
KORU Medical Systems $35.08 million 3.97 -$13.74 million ($0.11) -27.45

Titan Medical has higher earnings, but lower revenue than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Summary

KORU Medical Systems beats Titan Medical on 10 of the 15 factors compared between the two stocks.

About Titan Medical

(Get Free Report)

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

About KORU Medical Systems

(Get Free Report)

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.